期刊文献+

甲芬那酸分散片在健康人体内的药动学

Pharmacokinetics of mefenamic acid dispersible tablets in healthy volunteers
暂未订购
导出
摘要 目的建立测定人血清中甲芬那酸浓度的高效液相色谱检测法,并研究甲芬那酸分散片在健康人体内的药动学特征。方法甲芬那酸血清样品在酸性条件下,用乙腈-乙醚(2:1)混合液萃取。在DiscoveryC_(18)不锈钢分析色谱柱(4.6mm×250mm,5μm)上,以乙腈-水(55:45)(磷酸调pH=3.0)为流动相,流速1.8ml·min^(-1),检测波长280nm。结果测定方法的线性范围0.13~8.28mg·L^(-1),回归方程为ρ=3.903×10^(-6)A-0.01179(r=0.9993),血清中甲芬那酸的最低检测限为20mg·L^(-1)(按信噪比≥3计)。平均方法回收率为(97.30±4.54)%,日内与日间RSD均小于15%。药动学研究表明,甲芬那酸在12名健康人体内的主要药动学参数t_(max),ρ_(max),t_(1/2(Ke))和AUC(0~14h)分别为(1.04±0.50)h,(5.94±2.51)mg·L^(-1)。(2.12±0.69)h和(18.19±4.05)mg·h·L^(-1)。结论本方法具有良好的准确性、精密性和较高的灵敏度、简便快速,适用于甲芬那酸的血药浓度测定和药动学研究的需要。甲芬那酸分散片的药动学特征表现为达峰时间快,生物利用度较高。 OBJECTIVE To establish a simple HPLC assay for determining mefenamic acid in human serum and to study the pharmacokinetic characteristics of mefenamic acid dispersible tablets in healthy volunteers. METHODS The separation was performed on a Diseovery CIS (4.6mm×250 mm, 5μm)spectrum analytical column with the mobile phase consisted of acetonitrile-water (55:45, pH = 3.0) at the flow rate of 1.8 mL·min^-1. The detection wavelength was at 280 nm. RESULTS The linear calibration curve of mefenamic acid in serum was obtained over the range of 0.13 to 8.28 mg·L^-1( r = 0.999 3). The average recovery was(97.30±4.54)%. The inter-day and i ntra-day validation did not exceed 15%. The main pharmacokinetic parameters of mefenamic acid dispersible tables were as follows: tmax, ρmax, t1/2(Ke), AUC(0-14h)were(1.04±0.50)h,(5.94±2.51)mg·L^-1(2.12±0.69)h,(18.19±4.05)mg·h·L^-1,respectively.CONCLUSION The method is accurate and sensitive, simple, rapid, which may be used for blood concentration monitoring and pharmacokinetic study.
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2005年第19期1490-1492,共3页 Chinese Pharmaceutical Journal
关键词 甲芬那酸 药动学 高效液相色谱法 mefenamic acid pharmacokinetics HPLC
  • 相关文献

参考文献9

  • 1Mikami E, Goto T, Ohno T, et al. Simultaneous analysis of anthranilic acid derivatives in pharmaceuticals and human urine by high performance liquid chromatography with isocratic elution[ J ]. J Chromatogr B,2000,744: 81.
  • 2Al-Waili NS. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo[J].Eur J Med Res ,2000,5(4): 176.
  • 3文爱东,赵磊,张三奇,蒋永培,樊亚萱,杨志福.阿莫西林·克拉维酸钾片在健康志愿者体内的相对生物等效性[J].第四军医大学学报,2001,22(19):1805-1808. 被引量:15
  • 4文爱东,杨志福,赵磊,高迎春,李薇.酶联免疫法与微粒子酶免疫法检测全血他克莫司浓度的比较[J].中国医院药学杂志,2002,22(6):346-348. 被引量:11
  • 5Rouini MR, Asadipour A, Ardakani YH, et al. Liquid chromatography method for determination of mefenamic acid in human serum [ J ]. J Chromatogr B, 2004,800( 1-2 ): 189.
  • 6Ruiz TP, Lozano CM,Toma s V, et al. Analysis of binary mixtures of flufenamic, meclofenamic and mefenamic acids by derivative synchronous fluorescence spectrometry [ J ]. Talanta, 1998,47 ( 3 ): 537.
  • 7Perez-Ruiz T, Mart Lnez-Lozano C, Sanz A, et al. Determination of flufenamic, meclofenamic and mefenamic acids by capillary electrophoresis using β-cyclodextrin [ J]. J Chromatogr B, 1998,708 ( 1-2) :249.
  • 8陈鹰,匡长春,宋琪,汤韧,韩勇.分散片的研究与应用[J].中国药师,2001,4(1):62-64. 被引量:40
  • 9Rescigno A, Marzo A, Thyroff-friesinger A.Mefenamic acid equivalence assessment with a new statistical procedure [ J ]. Pharmacol Rese , 1996,34:3.

二级参考文献30

  • 1王孟琴,田淑媛.钾镁分散片的研制及临床观察[J].西北药学杂志,1994,9(4):175-176. 被引量:2
  • 2罗云,马红斌,蔡鸿生.扑热息痛分散片制备及质量控制[J].现代应用药学,1996,13(3):34-35. 被引量:4
  • 3王卓,韩丽梅,张晓青,邓英杰,张艳华,王越.利用均匀设计筛选阿司匹林分散片处方[J].沈阳药科大学学报,1996,13(4):235-239. 被引量:18
  • 4[1]Jiang H,Kobayashi M.Differences between cyclosporine A and tacrolimus in organ transplantation [J].Transplant Proc,1999,31:1978.
  • 5[2]Ihor B,Dawna D,Qais A.Effect of low-and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects[J].J Clin Pharmacol,2001,41:176.
  • 6[3]Macfarlane GD,Scheller D,Ersfeld BF,et al.Analytical characterization of the PRO-TracⅡELISA for the determination of tacrolimus in whole blood[J].Ther Drug Monit,1997,19:559.
  • 7[4]Kempe K,Densmore G,Macfarlane GD,et al.Comparison lf the lmx MEIA and PRO-Trac Ⅱ ELISA assays for the determination of tacrolimus in whole blood[J].Clinical Chemistry,1997,43:S205.
  • 8[5]Murthy JN,Chen Y,Warty VS,et al.Radioreceptor assay for quantifying FK506 immunosuppressant in whole blood[J].Clin Chem 1992,38:1307.
  • 9[6]Macfarlane GD,SchellerDG,Ersfeld DL,et al.Analytical validation lf the PRO_Trac ⅡELIsA for the determination of tacrolimus (FK506)in whole blood[J].Clin Chem,1999,45(9)L1449.
  • 10[7]Murthy JN,Davis DL,Yatscoff RW,et al.Tacrolimus metabolite cross-reactivity in different tacrlimus assays[J].Clin Biochem,1998,31(8):L613.

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部